BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220422T120000
DTEND;TZID=America/Vancouver:20220422T130000
DTSTAMP:20260419T083151
CREATED:20220418T193630Z
LAST-MODIFIED:20220418T193649Z
UID:19709-1650628800-1650632400@scienceinboston.com
SUMMARY:Stephen Quake Presentation: "A Decade of Molecular Cell Atlases"
DESCRIPTION:Join us as we welcome Dr. Quake (Stanford and Chan Zuckerberg Biohub) for a presentation on “A Decade of Molecular Cell Atlases” \nRestricted to MIT community.
URL:https://scienceinboston.com/event/stephen-quake-presentation-a-decade-of-molecular-cell-atlases/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220422T120000
DTEND;TZID=America/Vancouver:20220422T130000
DTSTAMP:20260419T083151
CREATED:20220418T193630Z
LAST-MODIFIED:20220418T193630Z
UID:27828-1650628800-1650632400@scienceinboston.com
SUMMARY:Stephen Quake Presentation: "A Decade of Molecular Cell Atlases"
DESCRIPTION:Join us as we welcome Dr. Quake (Stanford and Chan Zuckerberg Biohub) for a presentation on “A Decade of Molecular Cell Atlases” \nRestricted to MIT community.
URL:https://scienceinboston.com/event/stephen-quake-presentation-a-decade-of-molecular-cell-atlases-2/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220413T123000
DTEND;TZID=America/Toronto:20220413T133000
DTSTAMP:20260419T083151
CREATED:20220407T163458Z
LAST-MODIFIED:20220407T163458Z
UID:19573-1649853000-1649856600@scienceinboston.com
SUMMARY:A Macro View of Microdosing
DESCRIPTION:Microdosing psychedelics involves consuming doses that are one-twentieth to one-tenth the size of standard doses. The practice has become increasingly popular among individuals seeking to boost their productivity\, elevate their mood\, or treat symptoms of depression\, anxiety\, or pain. The increasing use of microdosing has inspired media coverage and scientific analysis of its costs and benefits. On April 13\, POPLAR will gather experts on the science\, law\, and business of microdosing for a panel discussion accompanied by a digital symposium on the Bill of Health. After a keynote address by Dr. James Fadiman\, a longtime microdosing scholar and advocate\, the event will turn to a panel discussion of the promise\, risks\, and future of microdosing psychedelics. \nPanelists\nIntroduction: Carmel Shachar\, Executive Director\, The Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School \nSarah Hashkes\, Co-Founder & CEO\, Radix Motion; Chief Technology Innovation Officer\, Red Light Holland \nDave Kopilak\, Shareholder\, Emerge Law Group \nErin Sharoni\, Chief Product Officer\, FOXO Technologies; Candidate for Master of Bioethics\, Harvard Medical School \nIfetayo Harvey\, Founder\, People of Color Psychedelic Collective \nModerator: Mason Marks\, MD\, JD\, Assistant Professor of Law\, University of New Hampshire Franklin Pierce School of Law; Senior Fellow and Project Lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School \nSponsored by the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School.
URL:https://scienceinboston.com/event/a-macro-view-of-microdosing/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220413T123000
DTEND;TZID=America/Toronto:20220413T133000
DTSTAMP:20260419T083151
CREATED:20220407T163458Z
LAST-MODIFIED:20220407T163458Z
UID:27827-1649853000-1649856600@scienceinboston.com
SUMMARY:A Macro View of Microdosing
DESCRIPTION:Microdosing psychedelics involves consuming doses that are one-twentieth to one-tenth the size of standard doses. The practice has become increasingly popular among individuals seeking to boost their productivity\, elevate their mood\, or treat symptoms of depression\, anxiety\, or pain. The increasing use of microdosing has inspired media coverage and scientific analysis of its costs and benefits. On April 13\, POPLAR will gather experts on the science\, law\, and business of microdosing for a panel discussion accompanied by a digital symposium on the Bill of Health. After a keynote address by Dr. James Fadiman\, a longtime microdosing scholar and advocate\, the event will turn to a panel discussion of the promise\, risks\, and future of microdosing psychedelics. \nPanelists\nIntroduction: Carmel Shachar\, Executive Director\, The Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School \nSarah Hashkes\, Co-Founder & CEO\, Radix Motion; Chief Technology Innovation Officer\, Red Light Holland \nDave Kopilak\, Shareholder\, Emerge Law Group \nErin Sharoni\, Chief Product Officer\, FOXO Technologies; Candidate for Master of Bioethics\, Harvard Medical School \nIfetayo Harvey\, Founder\, People of Color Psychedelic Collective \nModerator: Mason Marks\, MD\, JD\, Assistant Professor of Law\, University of New Hampshire Franklin Pierce School of Law; Senior Fellow and Project Lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School \nSponsored by the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School.
URL:https://scienceinboston.com/event/a-macro-view-of-microdosing-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220411T170000
DTEND;TZID=America/Vancouver:20220411T183000
DTSTAMP:20260419T083151
CREATED:20220404T194446Z
LAST-MODIFIED:20220404T194446Z
UID:19471-1649696400-1649701800@scienceinboston.com
SUMMARY:MIT Research Slam & 3 Minute Thesis
DESCRIPTION:Learn about cool research across MIT and celebrate inspiring communicators! Register to attend the MIT Research Slam Showcase\, a research communication competition for MIT Ph.D. students and postdocs. The showcase will feature 3-minute videos\, where participants explain their research and its significance in an engaging way to a general audience! \nThe program will include live viewing of finalist videos and evaluation by an expert panel of judges. Attendees can join in the fun and contribute their vote for the audience-choice awards\, as well as ask questions and leave comments. Come support MIT students and postdocs as they polish the important skill of communicating their research in a clear and concise manner. \nRegistration is open to the general public\, so help us spread the word at MIT and beyond! \nRegistration link: https://mit.zoom.us/webinar/register/WN_8qr3GQbJR82PnQl9ap6WqA
URL:https://scienceinboston.com/event/mit-research-slam-3-minute-thesis/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/04/2-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220411T170000
DTEND;TZID=America/Vancouver:20220411T183000
DTSTAMP:20260419T083151
CREATED:20220404T194446Z
LAST-MODIFIED:20220404T194446Z
UID:27824-1649696400-1649701800@scienceinboston.com
SUMMARY:MIT Research Slam & 3 Minute Thesis
DESCRIPTION:Learn about cool research across MIT and celebrate inspiring communicators! Register to attend the MIT Research Slam Showcase\, a research communication competition for MIT Ph.D. students and postdocs. The showcase will feature 3-minute videos\, where participants explain their research and its significance in an engaging way to a general audience! \nThe program will include live viewing of finalist videos and evaluation by an expert panel of judges. Attendees can join in the fun and contribute their vote for the audience-choice awards\, as well as ask questions and leave comments. Come support MIT students and postdocs as they polish the important skill of communicating their research in a clear and concise manner. \nRegistration is open to the general public\, so help us spread the word at MIT and beyond! \nRegistration link: https://mit.zoom.us/webinar/register/WN_8qr3GQbJR82PnQl9ap6WqA
URL:https://scienceinboston.com/event/mit-research-slam-3-minute-thesis-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/04/2-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220408T120000
DTEND;TZID=America/Toronto:20220408T160000
DTSTAMP:20260419T083151
CREATED:20220325T173329Z
LAST-MODIFIED:20220325T173329Z
UID:19379-1649419200-1649433600@scienceinboston.com
SUMMARY:2022 MIT Biotech Group Career Fair
DESCRIPTION:The MIT Biotech Group Career Fair is a one-day virtual event providing a platform for companies in the biotech\, biopharma\, medtech\, consulting\, IP/Law\, and VC/Finance spaces to connect with talent within the biotech community. The fair is a cross-MIT collaboration\, hosted by the MIT Biotech Group\, in partnership with the MIT Departments of Biology\, Biological Engineering\, Chemical Engineering\, Brain & Cognitive Sciences\, the Program of Health Sciences & Technology\, Computational & Systems Biology\, and the Institute for Medical Engineering and Science at MIT.
URL:https://scienceinboston.com/event/2022-mit-biotech-group-career-fair/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220408T120000
DTEND;TZID=America/Toronto:20220408T160000
DTSTAMP:20260419T083151
CREATED:20220325T173329Z
LAST-MODIFIED:20220325T173329Z
UID:27821-1649419200-1649433600@scienceinboston.com
SUMMARY:2022 MIT Biotech Group Career Fair
DESCRIPTION:The MIT Biotech Group Career Fair is a one-day virtual event providing a platform for companies in the biotech\, biopharma\, medtech\, consulting\, IP/Law\, and VC/Finance spaces to connect with talent within the biotech community. The fair is a cross-MIT collaboration\, hosted by the MIT Biotech Group\, in partnership with the MIT Departments of Biology\, Biological Engineering\, Chemical Engineering\, Brain & Cognitive Sciences\, the Program of Health Sciences & Technology\, Computational & Systems Biology\, and the Institute for Medical Engineering and Science at MIT.
URL:https://scienceinboston.com/event/2022-mit-biotech-group-career-fair-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220405T153000
DTEND;TZID=America/Toronto:20220405T183000
DTSTAMP:20260419T083151
CREATED:20220328T182245Z
LAST-MODIFIED:20220328T182245Z
UID:19437-1649172600-1649183400@scienceinboston.com
SUMMARY:Astellas Pharma Day
DESCRIPTION:Accelerate your biotech company\, startup\, or university’s innovation portfolio at our Astellas 2022 Pharma Day on April 5. \nMassBio’s Pharma Days® are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. \nDiscover on April 5 | Join Astellas’ open information session on April 5 for the latest insights on its R&D strategy\, target therapeutic areas\, and partnering capabilities. This session will be followed by a networking reception. This session will feature: \n\nHide Goto\, Ph.D.\, President\, Astellas Institute for Regenerative Medicine\nMichael Luther\, Ph.D.\, MBA\, Head of Early Stage Partnering\, Astellas\nMichael Patane\, Ph.D.\, President\, Mitobridge\nMat Pletcher\, Ph.D.\, Division Head of Gene Therapy Research & Technical Operations\, Astellas Gene Therapies\nJoanna Stanicka\, Ph.D.\, CEO and Founder\, Axonis
URL:https://scienceinboston.com/event/astellas-pharma-day-2/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220405T153000
DTEND;TZID=America/Toronto:20220405T183000
DTSTAMP:20260419T083151
CREATED:20220328T182245Z
LAST-MODIFIED:20220328T182245Z
UID:27823-1649172600-1649183400@scienceinboston.com
SUMMARY:Astellas Pharma Day
DESCRIPTION:Accelerate your biotech company\, startup\, or university’s innovation portfolio at our Astellas 2022 Pharma Day on April 5. \nMassBio’s Pharma Days® are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. \nDiscover on April 5 | Join Astellas’ open information session on April 5 for the latest insights on its R&D strategy\, target therapeutic areas\, and partnering capabilities. This session will be followed by a networking reception. This session will feature: \n\nHide Goto\, Ph.D.\, President\, Astellas Institute for Regenerative Medicine\nMichael Luther\, Ph.D.\, MBA\, Head of Early Stage Partnering\, Astellas\nMichael Patane\, Ph.D.\, President\, Mitobridge\nMat Pletcher\, Ph.D.\, Division Head of Gene Therapy Research & Technical Operations\, Astellas Gene Therapies\nJoanna Stanicka\, Ph.D.\, CEO and Founder\, Axonis
URL:https://scienceinboston.com/event/astellas-pharma-day-2-2/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220331T100000
DTEND;TZID=America/Vancouver:20220331T140000
DTSTAMP:20260419T083151
CREATED:20220204T230136Z
LAST-MODIFIED:20220307T173104Z
UID:18649-1648720800-1648735200@scienceinboston.com
SUMMARY:13th Annual Prostate Cancer Awareness Day
DESCRIPTION:Join leaders of legislature\, medicine and advocacy for the 13th Annual Prostate Cancer Awareness Day (PCAD) on March 31\, 2022\, between 10 am and 2 pm. It is organized by AdMeTech Foundation in cooperation with Prostate Cancer Action Council – and will be held virtually (prior to pandemic\, it has taken place at the Massachusetts State House since 2009). This event has created a Massachusetts model of national leadership in prostate cancer education and awareness since 2011\, when the state legislature had set a historic precedent by recognizing prostate cancer as a public health priority and leading health disparity in Black men. This year\, AdMeTech will announce launching a Prostate Cancer Equity Program to bring high quality care to every man. For more information\, visit www.admetech.org.
URL:https://scienceinboston.com/event/13th-annual-prostate-cancer-awareness-day/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/02/PCAD-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220331T100000
DTEND;TZID=America/Vancouver:20220331T140000
DTSTAMP:20260419T083151
CREATED:20220204T230136Z
LAST-MODIFIED:20220204T230136Z
UID:27804-1648720800-1648735200@scienceinboston.com
SUMMARY:13th Annual Prostate Cancer Awareness Day
DESCRIPTION:Join leaders of legislature\, medicine and advocacy for the 13th Annual Prostate Cancer Awareness Day (PCAD) on March 31\, 2022\, between 10 am and 2 pm. It is organized by AdMeTech Foundation in cooperation with Prostate Cancer Action Council – and will be held virtually (prior to pandemic\, it has taken place at the Massachusetts State House since 2009). This event has created a Massachusetts model of national leadership in prostate cancer education and awareness since 2011\, when the state legislature had set a historic precedent by recognizing prostate cancer as a public health priority and leading health disparity in Black men. This year\, AdMeTech will announce launching a Prostate Cancer Equity Program to bring high quality care to every man. For more information\, visit www.admetech.org.
URL:https://scienceinboston.com/event/13th-annual-prostate-cancer-awareness-day-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/02/PCAD-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220330T110000
DTEND;TZID=America/Toronto:20220330T125000
DTSTAMP:20260419T083151
CREATED:20220314T060621Z
LAST-MODIFIED:20220321T175433Z
UID:19224-1648638000-1648644600@scienceinboston.com
SUMMARY:Careers in Academia for Biomedical Students: Panel
DESCRIPTION:Now what? “I’m in a biomedical training program so I’m committed to a career in the biomedical sciences but frankly\, I’m not sure exactly what I want to do with my PhD/postdoctoral training. Actually\, I’m not even sure I know what’s out there!” Could this be you? If so\, you might want to join us to learn more about the biomedical workforce opportunities from those doing the work. We’re holding a series of panel discussions that will enable you to learn about various career opportunities\, in many cases through the lenses of our Boston University alumni. Don’t limit yourself as you might be surprised to learn about career paths you had not considered! \nRegistration: https://bostonu.zoom.us/meeting/register/tJcvcOmpqDsuHte6ihkvNJV-YNCC9Q6qd_Tr
URL:https://scienceinboston.com/event/careers-in-academia-for-biomedical-students-panel/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220330T110000
DTEND;TZID=America/Toronto:20220330T125000
DTSTAMP:20260419T083151
CREATED:20220314T060621Z
LAST-MODIFIED:20220314T060621Z
UID:27820-1648638000-1648644600@scienceinboston.com
SUMMARY:Careers in Academia for Biomedical Students: Panel
DESCRIPTION:Now what? “I’m in a biomedical training program so I’m committed to a career in the biomedical sciences but frankly\, I’m not sure exactly what I want to do with my PhD/postdoctoral training. Actually\, I’m not even sure I know what’s out there!” Could this be you? If so\, you might want to join us to learn more about the biomedical workforce opportunities from those doing the work. We’re holding a series of panel discussions that will enable you to learn about various career opportunities\, in many cases through the lenses of our Boston University alumni. Don’t limit yourself as you might be surprised to learn about career paths you had not considered! \nRegistration: https://bostonu.zoom.us/meeting/register/tJcvcOmpqDsuHte6ihkvNJV-YNCC9Q6qd_Tr
URL:https://scienceinboston.com/event/careers-in-academia-for-biomedical-students-panel-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220329T173000
DTEND;TZID=America/Toronto:20220329T183000
DTSTAMP:20260419T083151
CREATED:20220314T054913Z
LAST-MODIFIED:20220314T203412Z
UID:19210-1648575000-1648578600@scienceinboston.com
SUMMARY:SCIENCE with/in/sight: How Are Cancer Researchers Fighting COVID-19?
DESCRIPTION:The Koch Institute for Integrative Cancer Research at MIT cordially invites you to attend SCIENCE with/in/sight: How Are Cancer Researchers Fighting COVID-19? showcasing the work of MIT faculty and clinical investigators to address urgent and pressing needs related to the COVID-19 pandemic. \nThe third in a series of COVID-specific with/in/sight events\, this evening’s program will present updates from three projects begun in Spring 2020. \nPresenters: \nAngela Belcher\, PhD\nNovel materials for PPE\nJames Mason Crafts Professor; Head\, MIT Department of Biological Engineering \nMichael Yaffe\, MD\, PhD\nOvercoming respiratory distress\nDavid H. Koch Professor of Science; Intensive Care Physician\, Beth Israel Deaconess Medical Center \nHojun Li\, MD\, PhD\nOn-demand protective immunity testing\nCharles W. (1955) and Jennifer C. Johnson Clinical Investigator \nModerated by Jane Wilkinson\nExecutive Director\, Koch Institute at MIT \nTo register for in-person attendance visit https://www.eventbrite.com/e/272732118107 \nTo register for virtual attendance\, visit https://mit.zoom.us/webinar/register/WN_eSCrGGkLSmSRMQl_k3DC7A
URL:https://scienceinboston.com/event/science-with-in-sight-how-are-cancer-researchers-fighting-covid-19/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220329T173000
DTEND;TZID=America/Toronto:20220329T183000
DTSTAMP:20260419T083151
CREATED:20220314T054913Z
LAST-MODIFIED:20220314T054913Z
UID:27816-1648575000-1648578600@scienceinboston.com
SUMMARY:SCIENCE with/in/sight: How Are Cancer Researchers Fighting COVID-19?
DESCRIPTION:The Koch Institute for Integrative Cancer Research at MIT cordially invites you to attend SCIENCE with/in/sight: How Are Cancer Researchers Fighting COVID-19? showcasing the work of MIT faculty and clinical investigators to address urgent and pressing needs related to the COVID-19 pandemic. \nThe third in a series of COVID-specific with/in/sight events\, this evening’s program will present updates from three projects begun in Spring 2020. \nPresenters: \nAngela Belcher\, PhD\nNovel materials for PPE\nJames Mason Crafts Professor; Head\, MIT Department of Biological Engineering \nMichael Yaffe\, MD\, PhD\nOvercoming respiratory distress\nDavid H. Koch Professor of Science; Intensive Care Physician\, Beth Israel Deaconess Medical Center \nHojun Li\, MD\, PhD\nOn-demand protective immunity testing\nCharles W. (1955) and Jennifer C. Johnson Clinical Investigator \nModerated by Jane Wilkinson\nExecutive Director\, Koch Institute at MIT \nTo register for in-person attendance visit https://www.eventbrite.com/e/272732118107 \nTo register for virtual attendance\, visit https://mit.zoom.us/webinar/register/WN_eSCrGGkLSmSRMQl_k3DC7A
URL:https://scienceinboston.com/event/science-with-in-sight-how-are-cancer-researchers-fighting-covid-19-2/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220324T140000
DTEND;TZID=America/Toronto:20220324T150000
DTSTAMP:20260419T083151
CREATED:20220221T191046Z
LAST-MODIFIED:20220221T191046Z
UID:18925-1648130400-1648134000@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Diana Brainard\, AlloVir
DESCRIPTION:Diana Brainard\, MD\, is CEO of AlloVir\, a late-stage cell therapy company focused on developing innovative\, allogeneic\, off-the-shelf\, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases. She has more than 20 years of experience in the biopharmaceutical industry and academic medicine\, has authored more than 200 publications\, and brings a passion for advancing therapies for devastating diseases. \nPreviously\, Dr. Brainard spent more than a decade at Gilead\, where she played an enterprise-wide leadership role as the head of the virology therapeutic area overseeing the development and launch of some of the most successful drugs of the last decade including Sovaldi\, Harvoni\, Epclusa\, and Biktarvy. In 2020\, she led the company-wide initiative to rapidly advance remdesivir to become the first and only antiviral to receive regulatory approval for the treatment of SARS-CoV-2\, which earned her global recognition as one of the most influential people in the fight against SARS-CoV-2. Her industry career began at Merck\, where she held positions in clinical pharmacology and experimental medicine. \nDr. Brainard received her MD from Tulane University School of Medicine\, and her BA in comparative literature from Brown University. Following completion of her medical training\, she was on the faculty at Harvard Medical School\, where her NIH-funded research focused on HIV immunology and T-cell trafficking.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-diana-brainard-allovir/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220324T140000
DTEND;TZID=America/Toronto:20220324T150000
DTSTAMP:20260419T083151
CREATED:20220221T191046Z
LAST-MODIFIED:20220221T191046Z
UID:27812-1648130400-1648134000@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Diana Brainard\, AlloVir
DESCRIPTION:Diana Brainard\, MD\, is CEO of AlloVir\, a late-stage cell therapy company focused on developing innovative\, allogeneic\, off-the-shelf\, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases. She has more than 20 years of experience in the biopharmaceutical industry and academic medicine\, has authored more than 200 publications\, and brings a passion for advancing therapies for devastating diseases. \nPreviously\, Dr. Brainard spent more than a decade at Gilead\, where she played an enterprise-wide leadership role as the head of the virology therapeutic area overseeing the development and launch of some of the most successful drugs of the last decade including Sovaldi\, Harvoni\, Epclusa\, and Biktarvy. In 2020\, she led the company-wide initiative to rapidly advance remdesivir to become the first and only antiviral to receive regulatory approval for the treatment of SARS-CoV-2\, which earned her global recognition as one of the most influential people in the fight against SARS-CoV-2. Her industry career began at Merck\, where she held positions in clinical pharmacology and experimental medicine. \nDr. Brainard received her MD from Tulane University School of Medicine\, and her BA in comparative literature from Brown University. Following completion of her medical training\, she was on the faculty at Harvard Medical School\, where her NIH-funded research focused on HIV immunology and T-cell trafficking.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-diana-brainard-allovir-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220323T130000
DTEND;TZID=America/Vancouver:20220323T140000
DTSTAMP:20260419T083151
CREATED:20220314T055727Z
LAST-MODIFIED:20220314T055727Z
UID:19221-1648040400-1648044000@scienceinboston.com
SUMMARY:Finding Funding for Pediatric Medical Research: Meet the Thrasher Research Fund
DESCRIPTION:Looking for funding for pediatric medical research? Join this virtual workshop to learn more about the Thrasher Research Fund\, located in Salt Lake City\, which supports science that advances the diagnosis and treatment of children’s diseases. Thrasher currently funds research on childhood blindness\, nutritional deficiencies\, brain injuries\, diabetes\, asthma\, cancer\, genetic diseases\, and infectious diseases such as HIV\, malaria\, and tuberculosis. The fund favors projects that have strong potential for near-term clinical translation. \nThrasher holds two competitions per year for two separate grant programs: Thrasher Early Career Awards (offering grants of $25k) and\, for investigators at all career levels\, E.W. “Al” Thrasher Awards (offering grants of up to $500k). Distinctively\, Thrasher allows their awards to be used to supplement another grant and it funds both domestic and international projects. \nRegistration: https://www.bu.edu/research/featured-events/research-how-to-events/meet-the-thrasher-research-fund/
URL:https://scienceinboston.com/event/finding-funding-for-pediatric-medical-research-meet-the-thrasher-research-fund/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220323T130000
DTEND;TZID=America/Vancouver:20220323T140000
DTSTAMP:20260419T083151
CREATED:20220314T055727Z
LAST-MODIFIED:20220314T055727Z
UID:27819-1648040400-1648044000@scienceinboston.com
SUMMARY:Finding Funding for Pediatric Medical Research: Meet the Thrasher Research Fund
DESCRIPTION:Looking for funding for pediatric medical research? Join this virtual workshop to learn more about the Thrasher Research Fund\, located in Salt Lake City\, which supports science that advances the diagnosis and treatment of children’s diseases. Thrasher currently funds research on childhood blindness\, nutritional deficiencies\, brain injuries\, diabetes\, asthma\, cancer\, genetic diseases\, and infectious diseases such as HIV\, malaria\, and tuberculosis. The fund favors projects that have strong potential for near-term clinical translation. \nThrasher holds two competitions per year for two separate grant programs: Thrasher Early Career Awards (offering grants of $25k) and\, for investigators at all career levels\, E.W. “Al” Thrasher Awards (offering grants of up to $500k). Distinctively\, Thrasher allows their awards to be used to supplement another grant and it funds both domestic and international projects. \nRegistration: https://www.bu.edu/research/featured-events/research-how-to-events/meet-the-thrasher-research-fund/
URL:https://scienceinboston.com/event/finding-funding-for-pediatric-medical-research-meet-the-thrasher-research-fund-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220316T170000
DTEND;TZID=America/Toronto:20220316T180000
DTSTAMP:20260419T083151
CREATED:20220314T055608Z
LAST-MODIFIED:20220314T055608Z
UID:19218-1647450000-1647453600@scienceinboston.com
SUMMARY:Find Funding in Science & Engineering: Working with the Defense Advanced Research Projects Agency (DARPA)
DESCRIPTION:Are you interested in doing research at the leading edge of science and technology? The Defense Sciences Office (DSO) within the Defense Advanced Research Projects Agency (DARPA) identifies and pursues high-risk\, high-payoff research initiatives across a broad spectrum of science and engineering disciplines and transforms them into important\, new game-changing technologies for national security. Current DSO themes include frontiers in math\, computation and design\, limits of sensing and sensors\, complex social systems\, and anticipating capabilities for current and future threats. \nIn this virtual presentation to the BU research community\, Dr. Philip Root\, acting director of the DSO\, will provide an overview of DARPA\, how to work with DARPA and the Defense Sciences Office\, and the DSO’s current research activities and interests. Faculty will leave the talk with a better understanding of how to share their research with DARPA program managers and the types of research DARPA DSO is interested in supporting.
URL:https://scienceinboston.com/event/find-funding-in-science-engineering-working-with-the-defense-advanced-research-projects-agency-darpa/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220316T170000
DTEND;TZID=America/Toronto:20220316T180000
DTSTAMP:20260419T083151
CREATED:20220314T055608Z
LAST-MODIFIED:20220314T055608Z
UID:27818-1647450000-1647453600@scienceinboston.com
SUMMARY:Find Funding in Science & Engineering: Working with the Defense Advanced Research Projects Agency (DARPA)
DESCRIPTION:Are you interested in doing research at the leading edge of science and technology? The Defense Sciences Office (DSO) within the Defense Advanced Research Projects Agency (DARPA) identifies and pursues high-risk\, high-payoff research initiatives across a broad spectrum of science and engineering disciplines and transforms them into important\, new game-changing technologies for national security. Current DSO themes include frontiers in math\, computation and design\, limits of sensing and sensors\, complex social systems\, and anticipating capabilities for current and future threats. \nIn this virtual presentation to the BU research community\, Dr. Philip Root\, acting director of the DSO\, will provide an overview of DARPA\, how to work with DARPA and the Defense Sciences Office\, and the DSO’s current research activities and interests. Faculty will leave the talk with a better understanding of how to share their research with DARPA program managers and the types of research DARPA DSO is interested in supporting.
URL:https://scienceinboston.com/event/find-funding-in-science-engineering-working-with-the-defense-advanced-research-projects-agency-darpa-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220316T110000
DTEND;TZID=America/Toronto:20220316T125000
DTSTAMP:20260419T083151
CREATED:20220314T055451Z
LAST-MODIFIED:20220314T055513Z
UID:19214-1647428400-1647435000@scienceinboston.com
SUMMARY:Introduction to Science Policy
DESCRIPTION:What is science policy? How does the federal government impact scientific discovery\, and why should the scientific community care about what happens in Washington\, DC? Students will learn about the federal government’s role in science\, with a particular focus on funding\, regulations\, and current topics of debate. The class will also discuss the range of science policy careers and the skills one might need to pursue a job in science policy. \nRegistration: https://bostonu.zoom.us/meeting/register/tJUqc-iuqT4oGtEEpee2IbM4TW6qzNq09u2J
URL:https://scienceinboston.com/event/introduction-to-science-policy/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220316T110000
DTEND;TZID=America/Toronto:20220316T125000
DTSTAMP:20260419T083151
CREATED:20220314T055451Z
LAST-MODIFIED:20220314T055451Z
UID:27817-1647428400-1647435000@scienceinboston.com
SUMMARY:Introduction to Science Policy
DESCRIPTION:What is science policy? How does the federal government impact scientific discovery\, and why should the scientific community care about what happens in Washington\, DC? Students will learn about the federal government’s role in science\, with a particular focus on funding\, regulations\, and current topics of debate. The class will also discuss the range of science policy careers and the skills one might need to pursue a job in science policy. \nRegistration: https://bostonu.zoom.us/meeting/register/tJUqc-iuqT4oGtEEpee2IbM4TW6qzNq09u2J
URL:https://scienceinboston.com/event/introduction-to-science-policy-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220314T190000
DTEND;TZID=America/Toronto:20220314T200000
DTSTAMP:20260419T083151
CREATED:20220214T171620Z
LAST-MODIFIED:20220214T171620Z
UID:18827-1647284400-1647288000@scienceinboston.com
SUMMARY:The Code Breaker: A Conversation with Jennifer Doudna
DESCRIPTION:Join Ruth Lehmann\, Director\, Whitehead Institute as she speaks with Jennifer Doudna\, University of California\, Berkeley professor and Nobel Laureate\, about her role in the development of CRISPR-Cas9. They will discuss the potential applications of this world-changing genetic technology\, the societal and ethical implications of gene editing as well as current research projects\, collaborations\, and new advances in biology.
URL:https://scienceinboston.com/event/the-code-breaker-a-conversation-with-jennifer-doudna/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220314T190000
DTEND;TZID=America/Toronto:20220314T200000
DTSTAMP:20260419T083151
CREATED:20220214T171620Z
LAST-MODIFIED:20220214T171620Z
UID:27808-1647284400-1647288000@scienceinboston.com
SUMMARY:The Code Breaker: A Conversation with Jennifer Doudna
DESCRIPTION:Join Ruth Lehmann\, Director\, Whitehead Institute as she speaks with Jennifer Doudna\, University of California\, Berkeley professor and Nobel Laureate\, about her role in the development of CRISPR-Cas9. They will discuss the potential applications of this world-changing genetic technology\, the societal and ethical implications of gene editing as well as current research projects\, collaborations\, and new advances in biology.
URL:https://scienceinboston.com/event/the-code-breaker-a-conversation-with-jennifer-doudna-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220310T173000
DTEND;TZID=America/Vancouver:20220310T183000
DTSTAMP:20260419T083151
CREATED:20220218T185511Z
LAST-MODIFIED:20220221T185420Z
UID:18865-1646933400-1646937000@scienceinboston.com
SUMMARY:2022 Koch Institute Image Awards
DESCRIPTION:As we celebrate the opening of the 12th annual Image Awards exhibition\, the Koch Institute is proud to shine a light on the continued biomedical research happening at MIT. Join us on Zoom for live-streamed lightning talks by the  scientists and engineers behind this year’s award-winning visuals.
URL:https://scienceinboston.com/event/2022-image-awards/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220310T173000
DTEND;TZID=America/Vancouver:20220310T183000
DTSTAMP:20260419T083151
CREATED:20220218T185511Z
LAST-MODIFIED:20220218T185511Z
UID:27810-1646933400-1646937000@scienceinboston.com
SUMMARY:2022 Koch Institute Image Awards
DESCRIPTION:As we celebrate the opening of the 12th annual Image Awards exhibition\, the Koch Institute is proud to shine a light on the continued biomedical research happening at MIT. Join us on Zoom for live-streamed lightning talks by the  scientists and engineers behind this year’s award-winning visuals.
URL:https://scienceinboston.com/event/2022-image-awards-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220310T090000
DTEND;TZID=America/Vancouver:20220310T101500
DTSTAMP:20260419T083151
CREATED:20220307T190200Z
LAST-MODIFIED:20220307T190200Z
UID:19122-1646902800-1646907300@scienceinboston.com
SUMMARY:Harvard Startup Stories: Beacon Bio
DESCRIPTION:Hop on Zoom for this lunchtime talk featuring the founder of Beacon Bio\, a biomedical device startup which launched to commercialize innovations developed at Harvard SEAS\, Harvard’s Wyss Institute\, and Mass Eye & Ear. \nFeatured speaker: \nNicole Black\, PhD ’20\, founder and CEO of Beacon Bio and now Vice President of Biomaterials and Innovation at Desktop Health. \nDr. Black founded Beacon Bio to commercialize a biomimetic hearing-restoration technology developed at Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS)\, the Wyss Institute for Biologically Inspired Engineering at Harvard University\, and Mass Eye & Ear. Dr. Black had advanced this research as a SEAS doctoral student in the lab of Prof. Jennifer Lewis\, and the work was advanced toward commercialization as an Institute Project at the Wyss. The core technology\, called the PhonoGraft device\, is a 3D-printed\, biocompatible graft that could be implanted to repair a damaged eardrum. If its clinical development is successful\, the PhonoGraft technology could mitigate the pain\, drainage\, and hearing loss associated with ear drum perforations that affect millions of individuals worldwide. Shortly after its launch\, Beacon Bio was acquired by California-based Desktop Health\, a healthcare business within Desktop Metal Inc. that focuses on new 3D printing and biofabrication solutions for personalized medicine. Dr. Black\, who was CEO of Beacon Bio and is a Wyss Lumineer\, continues to lead the platform as Vice President of Biomaterials and Innovation at Desktop Health. Read more about the launch and acquisition of Beacon Bio. \nShe will be joined by Chris Petty\, PhD\, Director of Business Development in Harvard Office of Technology Development.
URL:https://scienceinboston.com/event/harvard-startup-stories-beacon-bio/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220310T090000
DTEND;TZID=America/Vancouver:20220310T101500
DTSTAMP:20260419T083151
CREATED:20220307T190200Z
LAST-MODIFIED:20220307T190200Z
UID:27815-1646902800-1646907300@scienceinboston.com
SUMMARY:Harvard Startup Stories: Beacon Bio
DESCRIPTION:Hop on Zoom for this lunchtime talk featuring the founder of Beacon Bio\, a biomedical device startup which launched to commercialize innovations developed at Harvard SEAS\, Harvard’s Wyss Institute\, and Mass Eye & Ear. \nFeatured speaker: \nNicole Black\, PhD ’20\, founder and CEO of Beacon Bio and now Vice President of Biomaterials and Innovation at Desktop Health. \nDr. Black founded Beacon Bio to commercialize a biomimetic hearing-restoration technology developed at Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS)\, the Wyss Institute for Biologically Inspired Engineering at Harvard University\, and Mass Eye & Ear. Dr. Black had advanced this research as a SEAS doctoral student in the lab of Prof. Jennifer Lewis\, and the work was advanced toward commercialization as an Institute Project at the Wyss. The core technology\, called the PhonoGraft device\, is a 3D-printed\, biocompatible graft that could be implanted to repair a damaged eardrum. If its clinical development is successful\, the PhonoGraft technology could mitigate the pain\, drainage\, and hearing loss associated with ear drum perforations that affect millions of individuals worldwide. Shortly after its launch\, Beacon Bio was acquired by California-based Desktop Health\, a healthcare business within Desktop Metal Inc. that focuses on new 3D printing and biofabrication solutions for personalized medicine. Dr. Black\, who was CEO of Beacon Bio and is a Wyss Lumineer\, continues to lead the platform as Vice President of Biomaterials and Innovation at Desktop Health. Read more about the launch and acquisition of Beacon Bio. \nShe will be joined by Chris Petty\, PhD\, Director of Business Development in Harvard Office of Technology Development.
URL:https://scienceinboston.com/event/harvard-startup-stories-beacon-bio-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR